The Incretin Space

A collection of collated data on incretin drug developments, including new drugs, new treatments and the future of incretin in medicine

ADA Conference 2025: Orforglipron & Bimagrumab

Lilly's oral non-peptide GLP-1 could change everything & bimagrumab flexes its muscle, but at what cost?

More novel molecules, more side effects

Novo's Dual Amylin-GLP1 agonist shows promise but caveats apply

The next revolution in medicine arrives in 2026

(Ant)agonizing over glucose, and the next medical revolution